Investment Rating - The investment rating for the company has been adjusted from "Buy" to "Hold" [3][5]. Core Insights - The company is experiencing business pressure due to a slowdown in domestic investment and financing, leading to a significant decline in revenue and profit for 2024. Revenue is projected at 2.018 billion yuan, a year-on-year decrease of 15.07%, with net profit dropping by 81.34% to 74 million yuan [1][2]. - The laboratory business contributed 50 million yuan, while asset management income was 90 million yuan, and the fair value change of biological assets was -110 million yuan, indicating a substantial decline in profitability compared to the previous year [2]. - Despite the current challenges, there is an expectation of marginal improvement in domestic demand over the next three years due to ongoing government policies encouraging innovation, which may benefit the company as a key player in the domestic preclinical CRO business [2]. Financial Performance Summary - For 2024, the company is expected to generate revenue of 2.018 billion yuan, with a year-on-year decline of 15.1%. The net profit is projected at 74 million yuan, reflecting a significant drop of 81.3% [9][11]. - The gross margin is expected to decrease to 28.4% in 2024, with earnings per share (EPS) forecasted at 0.10 yuan [9][11]. - Revenue forecasts for 2025 to 2027 have been adjusted to 1.995 billion yuan, 2.043 billion yuan, and 2.166 billion yuan, respectively, with EPS estimates of 0.50 yuan, 0.48 yuan, and 0.50 yuan [3][9]. Order and Market Trends - The company signed new orders worth 1.84 billion yuan in 2024, a decline of 20% year-on-year, with domestic orders falling by 25.5% to 1.46 billion yuan, while overseas orders increased by 11.8% to 380 million yuan [2][9]. - The core preclinical research business generated 1.92 billion yuan in revenue, down 17% year-on-year, with domestic clients contributing 1.48 billion yuan and international clients 440 million yuan [2][9].

Investment Rating - The investment rating for the company is "Accumulate" [1] Core Views - The company reported a total revenue of 5.357 billion yuan in 2024, a year-on-year decrease of 24.41%, and a net profit attributable to shareholders of 346 million yuan, down 80.46% year-on-year [2] - The decline in performance is attributed to pressure on demand and channel management, leading to inventory reduction [3] - The company has established a joint venture with Yelang Ancient Liquor Industry, which achieved a revenue of 264 million yuan, a year-on-year increase of 47.78% [4] - The company is transitioning to a more refined channel strategy and has implemented an equity incentive plan to support performance [6][8] Summary by Sections Financial Performance - In 2024, the company experienced a significant decline in revenue and profit, with high-end and ordinary liquor revenues decreasing by 27.66% and 23.42% respectively [3] - The sales volume for high-end and ordinary liquor fell by 12.09% and 41.69%, while the price per ton for high-end liquor dropped by 17.71% [3] - The company’s revenue from domestic and foreign markets was 1.511 billion yuan and 3.277 billion yuan respectively, with a more significant decline in foreign sales [5] Strategic Initiatives - The company plans to focus on major products, high-end positioning, national expansion, and internationalization in 2025 [6] - The equity incentive plan involves granting up to 203,660 shares at a price of 28.78 yuan per share, with performance targets set for revenue and net profit growth from 2025 to 2027 [8] Future Outlook - The company is expected to achieve a recovery in performance in 2025, with projected revenues of 6.061 billion yuan and net profits of 913 million yuan [9] - The earnings per share (EPS) is forecasted to be 2.75 yuan in 2025, with a price-to-earnings (PE) ratio of 20 times [9]

Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company is expected to experience significant revenue growth driven by both domestic demand and international exports, particularly in military trade and advanced training aircraft [2][3][4][5][6][9] Summary by Sections Financial Overview - The company reported a revenue of 5.25 billion yuan for 2024, representing a year-on-year increase of 40.9% [2] - The net profit attributable to the parent company for 2024 is projected to be 39.24 million yuan, up 20.7% year-on-year [2] - Revenue forecasts for 2025, 2026, and 2027 are 8.18 billion yuan, 11.23 billion yuan, and 13.91 billion yuan respectively, with corresponding net profits of 186 million yuan, 281 million yuan, and 378 million yuan [9][11] Military Trade - The company achieved a substantial increase in overseas revenue, reaching 1.32 billion yuan in 2024, a year-on-year growth of 548% [3] - The L15 advanced trainer aircraft is highlighted as a cost-effective product with potential to replace light combat aircraft, indicating a broad export market [3] Domestic Demand - The company anticipates a doubling of daily related transaction sales in 2025, indicating a significant increase in demand for trainer aircraft and missiles [4] - Contracts worth 6.446 billion yuan have been signed but not yet fulfilled, expected to contribute to revenue in 2025 [4] Drone Development - The company is positioned to enter a phase of increased demand for drones, with a growing trend in military applications globally [5] Large Aircraft Projects - The C919 aircraft project is accelerating deliveries, with the company supporting increased production capacity from 50 to 75 units per year [6] Low-altitude Aircraft - The company has received necessary certifications for its initial training aircraft, which has entered the civil aviation market and secured multiple orders [8] Investment Recommendations - The company is recognized as the only platform in China for the assembly of aircraft and missiles, with a diversified product range that is expected to lead to a rebound in performance and rapid growth [9]

证券研究报告|金融工程研究报告 [Table_Title] 量价行业轮动组合 3 月上涨 0.56% [Table_Title2] ——行业轮动组合月报 [Table_Summary] ► 量价行业轮动组合 3 月上涨 0.56% 2010 年至 2025 年 3 月，量价行业轮动组合的累计收益为 707.32%，相对于全部行业等权组合的累计超额为 613.37%。 量价行业轮动组合 3 月份上涨 0.56%，相对于行业等权的超额 收益为 0.53%。 2025 年 4 月份量价复合因子值排名较高的行业为：家 电、银行、轻工制造、交通运输、房地产。 风险提示 报告的结论基于历史统计规律，当历史规律发生改变 时，报告中的结论可能失效。市场可能出现超预期波动风 险。 评级及分析师信息 [Table_Author] 分析师：丁睿雯 邮箱：dingrw@hx168.com.cn SAC NO：S1120523040002 [Table_Date] 2025 年 4 月 1 日 分析师：杨国平 邮箱：yanggp@hx168.com.cn SAC NO：S1120520070002 请仔细阅读在本报告尾部的重要法律声明 ...

Investment Rating - The investment rating for the company is "Accumulate" [1] Core Views - The company reported a significant decline in revenue and net loss for 2024, primarily due to slow recovery in post-real estate consumption and a temporary drop in rental income [2][3] - The company is leveraging government subsidies to boost sales and improve occupancy rates in its malls, with a notable increase in "trade-in" orders and sales during Q4 2024 [3] - The company is focusing on high-end home appliance and home decoration ecosystems to enhance its market position and operational quality [5][6] Revenue Summary - In 2024, the company achieved revenue of 7.82 billion, a year-on-year decline of 32.08%, with a net loss attributable to shareholders of 2.98 billion [2][9] - The company's self-operated malls generated revenue of 5.36 billion, down 21.0% year-on-year, with average occupancy rates of 83.0% and 82.5% for self-operated and managed malls, respectively [3] Profitability Summary - The company's gross margin for 2024 was 58.26%, an increase of 1.52 percentage points year-on-year, while the net margin was -40.79%, a decline of 20.20 percentage points [4] - The company’s operating expenses increased significantly, with a total expense ratio of 58.24% for 2024, up 11.64 percentage points year-on-year [4] Future Outlook - The company has adjusted its revenue forecasts for 2025-2027, expecting revenues of 8.20 billion, 8.50 billion, and 8.78 billion, respectively, with corresponding EPS of 0.02, 0.09, and 0.16 [7][9] - The company maintains a comprehensive online and offline layout, covering home furnishings, home decoration, and high-end appliances, which is expected to enhance its growth potential [7]

Group 1: PMI Overview - The manufacturing PMI for March is 50.5%, matching expectations and slightly up from 50.2% in the previous month[1] - The non-manufacturing PMI is at 50.8%, an increase from 50.4% previously[1] - Overall, both manufacturing and non-manufacturing sectors show signs of demand recovery, with new orders in manufacturing up by 0.2 percentage points (pct) and supplier delivery times improving by 0.1 pct[1] Group 2: Year-on-Year Comparisons - Compared to the first quarter of last year, manufacturing shows stronger performance with production and new orders at 4.9% and 2.1% respectively, up from 3.3% and 1.0% last year[2] - Non-manufacturing production and new orders are at 1.4% and -10.9%, significantly lower than last year's 5.1% and -8.2%[2] - The average composite PMI for Q1 is 50.9%, below last year's 51.5% and Q4's 51.3%[2] Group 3: New Momentum and Employment - The EPMI for March is 59.6%, rebounding by 10.6 pct, indicating strong new momentum in manufacturing[3] - Employment in manufacturing and services has slightly declined, with manufacturing at 48.2% and services at 46.5%[5] - The construction sector saw a significant drop in employment to 41.4%, indicating potential challenges in job creation[5] Group 4: Export Orders and Price Trends - New export orders in manufacturing increased by 0.4 pct to 49.0%, but remain below last year's 51.3%[4] - Price indices across manufacturing, construction, and services have declined, indicating weak pricing power, with service prices at a low of 46.6%[4] - The government has set a 2% inflation target for the year, but current price trends suggest a gap to this target[4] Group 5: Market Implications - The report suggests that there is no immediate concern regarding export risks, as new export orders continue to recover[7] - The bond market's focus will be on liquidity conditions in April and the impact of U.S. tariffs on market sentiment[7] - There is a likelihood of monetary easing in April-May, with a potential for reserve requirement ratio cuts, but interest rate cuts may depend on external uncertainties[7]

证券研究报告|公司动态报告 [Table_Date] 2025 年 03 月 31 日 [Table_Title] 风起东方，灼灼其华 [Table_Title2] 曼卡龙(300945) [Table_Summary] 围绕东方美学与时尚珠宝，区域强势品牌向全国拓展。 曼卡龙定位于"每一天的珠宝"，以都市时尚女性为目标消费人 群，主营业务收入来源于素金饰品及镶嵌饰品，覆盖东方时尚 和国际轻奢两大赛道。公司拥有"MCLON 曼卡龙"、"OWNSHINE 慕璨"、设计师品牌"Ātman"、"宝若岚"等珠宝首饰品牌。 24Q1-Q3，公司实现营收 16.73 亿元，同比+37.4%，实现归母净 利润 0.77 亿元，同比+12.5%。 产品端：深耕黄金戒指细分品类，凤华升级为子品牌。 公司数字化的本质是数字驱动经营和管理，核心是全渠道一体化 的综合平台项目的布局和建设。1）搭建中台系统，实现主要环 节数据透明化。2）基于数据驱动的用户运营与高效营销。 ► 品牌营销强化客户心智。 产品推广与品牌营销同步进行。公司的营销推广活动采取两条 评级及分析师信息 | [Table_Rank] 评级： | 增持 | | --- ...

Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company's revenue for 2024 is projected to be 2.79 billion, with a net profit of 240 million, reflecting a year-on-year decline of 7.7% in revenue and an increase of 27.0% in net profit [2] - The decline in revenue is attributed to intensified competition and changes in examination schedules affecting enrollment [3] - AI technology is expected to enhance teaching efficiency and operational effectiveness, contributing to a potential increase in profit margins [5] Summary by Sections Revenue and Profitability - The company's revenue for 2024 is expected to be 2.79 billion, with a net profit of 240 million, showing a year-on-year decrease of 7.7% in revenue and an increase of 27.0% in net profit [2] - The adjusted net profit margin for 2024 is projected at 13%, down 1.7 percentage points from the previous year [5] Business Segments - Revenue from training services and book sales for 2024 is expected to be 2.34 billion and 450 million, respectively, representing declines of 6.9% and 11.4% year-on-year [3] - The average monthly active users on the platform for 2024 is projected to remain stable at 9.1 million [3] Financial Forecasts - Revenue forecasts for 2025 and 2026 have been adjusted down to 2.84 billion and 2.98 billion, respectively, with a new revenue forecast for 2027 set at 3.15 billion [6] - The adjusted net profit forecasts for 2025 and 2026 have been revised down to 373 million and 396 million, respectively, with a new forecast for 2027 at 423 million [6] Valuation Metrics - The projected price-to-earnings (PE) ratios for 2025, 2026, and 2027 are 14.24, 13.44, and 12.56, respectively [8] - The expected earnings per share (EPS) for 2025, 2026, and 2027 are 0.17, 0.18, and 0.19, respectively [8]

Investment Rating - Industry rating: Recommended [5] Core Insights - In Q4 2024, finished nickel and cobalt production increased by 3% and 41% year-on-year, respectively, with nickel net direct cash costs decreasing by 31% to $5.44 per pound [1][2] - The average realized price for nickel in Q4 2024 was CAD 9.98 per pound, down 8% year-on-year, while cobalt's average reference price was CAD 12.30 per pound, down 29% [2] - The company reported a significant increase in sales volume for finished nickel and cobalt, with Q4 2024 sales reaching 4,326 tons and 465 tons, respectively, marking a 23% and 17% increase year-on-year [1][6] Summary by Sections Production and Operational Performance - In Q4 2024, the Moa joint venture produced 3,853 tons of finished nickel and 465 tons of cobalt, reflecting a year-on-year increase of 3% and 41% [1] - The total production for finished nickel and cobalt in 2024 was 15,166 tons and 1,603 tons, respectively [4] - The production of ammonium sulfate fertilizer in Q4 2024 was 67,600 tons, an 11% increase year-on-year, with sales rising by 14% [1] Financial Performance - Q4 2024 revenue from the metals business was CAD 148 million, a 48% increase year-on-year, driven by a 23% increase in nickel sales volume [9] - The overall revenue for 2024 was CAD 158.8 million, a 29% decrease compared to the previous year [19] - The adjusted EBITDA for Q4 2024 was CAD 15.4 million, compared to a loss of CAD 7 million in the same quarter last year [18] Future Outlook - For 2025, the company expects finished nickel and cobalt production to be between 31,000 - 33,000 tons and 3,300 - 3,600 tons, respectively, indicating an increase from 2024 [20] - The Moa JV expansion plan is progressing, with the first phase completed and the second phase expected to enhance production capacity [23] - The company is advancing its nickel-cobalt hydroxide MHP project, aiming to convert nickel intermediates into high-purity nickel and cobalt for the electric vehicle supply chain [25]

证券研究报告|港股公司点评报告 [Table_Date] 2025 年 03 月 31 日 [Table_Title] 业绩符合预期，期待原奶周期反转 [Table_Title2] 现代牧业(1117.HK) | [Table_DataInfo] 评级： | 买入 | 股票代码： | 1117 | | --- | --- | --- | --- | | 上次评级： | 买入 | 52 周最高价/最低价(港元)： | 0.91/0.63 | | 目标价格(港元)： | | 总市值(亿港元) | 90.24 | | 最新收盘价(港元)： | 1.14 | 自由流通市值(亿港元) | 90.24 | | | | 自由流通股数(百万) | 7,915.66 | [Table_Summary] 事件概述 公司 24FY 实现营业收入 132.5 亿元，同比-1.5%，实现股东应占亏损 14.7 亿元，去年同期为实现盈利 1.9 亿元。据此推算，公司 24H2 实现营业收入 68.4 亿元，同比基本持平，实现股东应占亏损 12.6 亿元，去年同 期为亏损 0.3 亿元。公司业绩表现符合之前盈利预警预期。 分析判断: ► ...